🔎 Trials Near Me

Home › Essential Thrombocythemia › Massachusetts

Pag-aaral pangklinika para sa Essential Thrombocythemia sa Massachusetts

4 pag-aaral para sa Essential Thrombocythemia ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center (Bidmc), Boston
  • University of Massachusetts Medical School, Worcester
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07623200

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002

Ruxolitinib in Thrombocythemia and Polycythemia Vera

  • Massachusetts General Hospital, Boston
  • Beth-Israel Deaconess Medical Center, Boston
  • Dana Farber Cancer Institute, Boston
  • at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT04644211

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.